Equilibrium and transient intermediates in folding of human macrophage migration inhibitory factor

European Journal of Biochemistry

Volumn 260, Issue 3, 1999, Pages 609-618

  Žerovnik, Eva ^a   Janjić, Vojko ^a   Francky, Andrej ^b   Mozetič Francky, Bojana ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b Biohit DOO   (Slovenia)

Author keywords

Acid denaturation; Folding intermediates; Kinetics of folding; Macrophage migration inhibitory factor; MIF; Molten globule

Indexed keywords

GUANIDINE; MIGRATION INHIBITION FACTOR; UREA;

ARTICLE; CIRCULAR DICHROISM; DENATURATION; DENSITY GRADIENT CENTRIFUGATION; FLUOROMETRY; GEL PERMEATION CHROMATOGRAPHY; MACROPHAGE MIGRATION INHIBITION; PH; PRIORITY JOURNAL; PROTEIN FOLDING;

CIRCULAR DICHROISM; ESCHERICHIA COLI; GUANIDINE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; PROTEIN DENATURATION; PROTEIN FOLDING; RECOMBINANT PROTEINS; UREA;

EID: 0033559684     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00170.x     Document Type: Article

References (66)

1. Bloom, B.R. & Bennett, B. (1966) Mechanism of a reaction in vitro associated with delayed type hypersensitivity. Science 153, 80-82.
2. David, J.R. (1966) Delayed hypersensitivity in vitro: its mediators by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA 65, 72-77.
3. Al-Askari, S., David, J.R., Lawrence, H.S. & Thomas, L. (1965) In vitro studies on homograft sensitivity. Nature 205, 916-917.
4. Burmeister, G., Zwadlo, G., Michels, E., Brocker, E. & Sorg, C. (1984) Use of a monoclonal antibody for the detection of human macrophage migration inhibitory factors (MIFs) in isolated cells and tissues. Lymphokine Res. 3, 236.
5. Churchill, W.H., Piessens. W.F., Sulis, C.A. & David, J.R. (1975) Macrophage activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J. Immunol. 115, 781.
6. David, J.R. & David, R.A. (1972) Cellular hypersensitivity and immunity. Prog. Allergy 16, 300-449.
7. Harrington, J.T. (1977) Involvement of lymphocyte mediators in the rejection of a murine tumor allograft. Cell. Immunol. 30, 261-271.
8. Nathan, C.F., Karnovsky, M.L. & David, J.R. (1971) Alterations of macrophage functions by mediator from lymphocytes. J. Exp. Med. 133, 1356.
9. Nathan, C.F., Remold, H.G. & David, J.R. (1973) Characterisation of a lymphocyte factor which alters macrophage functions. J. Exp. Med. 137, 275.
10. Schlegel Gomez, R., Diepgen, T.L., Neumann, C. & Sorg, C. (1990) Detection of migration inhibitory factor (MIF) by a monoclonal antibody in the microvasculature of inflamed skin. Arch. Dermatol. Res. 282, 374-378.
11. Weisser, W.Y., Temple, P.A., Witek-Giannotti, J.S., Remold, H.G., Clark, S.C. & David, J.R. (1989) Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor, Proc. Natl Acad. Sci. USA 86, 7522-7526.
12. Bernhagen, J., Calandra, T., Mitchell, R.A., Martin, S.B., Tracey, K.J., Voelter, W., Manogue, K.R., Cerami, A. & Bucala, R. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759.
13. Bernhagen, J., Mitchell, R.A., Calandra, T., Voelter, W., Cerami, A. & Bucala, R. (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33, 14144-14155.
14. Calandra, T., Bernhagen, J., Mitchell, R.A. & Bucala, R. (1994) The macrophage is an important and previously unrecognised source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902.
15. Bacher, M., Metz, C.N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T. & Bucala, R. (1996) An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl Acad. Sci. USA 93, 7849-7854.
16. Bernhagen, J., Bacher, M., Calandra, T., Metz, C.N., Doty, S.B., Donnelly, T. & Bucala, R. (1996) An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med. 183, 277-282.
17. Bucala, R. (1996) MIF re-discovered: pituitary hormone and glukokorticoid-induced regulator of cytokine production. Cytokine Growth Factor Rev. 7, 19-24.
18. Calandra, T., Bernhagen, J., Metz, C.N., Spiegel, L.A., Bacher, M., Donnelly, T., Cerami, A. & Bucala, R. (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 376, 68-71.
19. Lanahan, A., Williams, J.B., Sanders, L.K. & Nathans, D. (1992) Growth factor-induced delayed early response genes. Mol. Cell. Biol. 12, 3919-3929.
20. Wistow, G.J., Shaughnessy, M.P., Lee, D.C., Hodin, J. & Zelenka, P.S. (1993) A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc. Natl Acad. Sci. USA 90, 8049-8052.
21. Kleeman, R., Kapurniotu, A., Frank, R.W., Gessner, A., Mischke, R., Flieger, O., Jüttner, S., Brunner, H. & Bernhagen, J. (1998) Disulfide analysis reveals a role for a macrophage migration inhibitory factor MIF as a thiol-protein oxidoreductase. J. Mol. Biol. 280, 85-102.
22. Galat, A., Riviere, S. & Bouet, F. (1993) Purification of macrophage migration inhibitory factor (MIF) from bovine brain cytosol. FEBS Lett. 319, 233-236.
23. Galat, A., Riviere, S., Bouet, F. & Menez, A. (1994) A diversified family of 12-kDa proteins with a high amino acid sequence similarity to macrophage migration inhibitory factor (MIF). Eur. J. Biochem. 224, 417-421.
24. Sun, H.W., Bernhagen, R., Bucala, R. & Lolis, E. (1996a) Crystal structure at 2.6 Å resolution of human macrophage migration inhibitory factor. Proc Natl Acad. Sci. USA 93, 5191-5196.
25. Suzuki, M., Sugimoto, H., Nakagawa, A., Tanaka, I., Nishihira, J. & Sakai, M. (1996) Crystal structure of the macrophage migration inhibitory factor from mt liver. Nature Struc. Biol. 3, 259-266.
26. Mühlhahn, P., Bernhagen, J., Czisch, M., Georgescu, J., Renner, C., Ross, A., Bucala, R. & Holak, T.A. (1996) NMR characterization of structure, backbone dynamics, and glutathione binding of the human MIF. Protein Sci. 5, 2095-2103.
27. Sun, H.W., Swope, M., Cinquina, C., Bedarkar, S., Bernhagen, J., Bucala, R. & Lolis, E. (1996b) The subunit structure of human macrophage migration inhibitory factor: evidence for a trimer. Prot. Engineering 9, 631-635.
28. Mischke, R., Kleemann, R., Brunner, H. & Bernhagen, J. (1998) Cross-linking and mutational analysis of the oligomerization state of the cytokine macrophage migration inhibitory factor (MIF). FEBS Lett. 427, 85-90.
29. Nishihira, J., Kuriyama, T., Nishino, H., Ishibashi, T., Sakai, M. & Nishi, S. (1993) Purification and characterisation of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure. Biochem. Mol. Biol. Int. 31, 841-850.
30. Mozetič-Francky, B., Cotiè, V., Ritonja, A., Žerovnik, E. & Francky, A. (1997) High-yield expression and purification of recombinant human macrophage migration inhibitory factor. Prot. Express. Purif. 9, 115-124.
31. Žerovnik, E., Jerala, R., Kroon-Žitko, L., Turk, V. & Lohner, K. (1997) Characterization of the equilibrium intermediates in acid denaturation of human stefin B. Eur. J. Biochem. 245, 364-372.
32. Žerovnik, E., Jerala, R., Poklar, N., Kroon-Žitko, L. & Turk, V. (1994) Compactness of the molten globule in comparison to unfolded states as observed by size-exclusion chromatography. Biochim. Biophys. Acta 1209, 140-143.
33. Cantor, C.R. & Schimmel, P.R. (1980) Biophysical Chemistry. Part III: the Behavior of Biological Macromolecules. Freeman and Co, San Francisco, USA.
34. Santoro, M.M. & Bolen, D.W. (1988) Unfolding frae energy change determined by the linear extrapolation method. 1. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry 27, 8063-8068.
35. Semisotnov, G.V., Rodionova, N.A., Razgulyaev, O.I., Uversky, V.N., Gripas, A.F. & Gilmanshin, R.I. (1991) Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31, 119-128.
36. Dabora, J.M. & Marquesse, S. (1994) Equilibrium unfolding of Escheria coli ribonuclease H: characterization of a partially folded state. Protein Sci. 3, 1401-1408.
37. Das, B.K., Bhattacharyya, T. & Roy, S. (1995) Characterization of urea induced molten globule intermediate state of glutaminyl-t RNA synthetase from E. coli. Biochemistry 34, 5242-5247.
38. Misselwitz, R., Hausdorf, G., Welfe, K., Höhne, W.E. & Welfle, H. (1995) Conformation and stability of recombinant HIV-1 capsid protein p24 (rp24). Biochim. Biophys. Acta 1250, 9-18.
39. Janjić, V. (1996) Chemical and pH denaturation of MIF. BSc Thesis, University of Ljubljana.
40. Van Dael, H., Haezenbrouck, E., Pardon, E. & Joniau, M. (1997). Conformational stability of LYLA1, a synthetic chimera of human lysozyme and bovine α-lactalbumine. Eur. Biophys. J. 25, 171-179.
41. Haezenbrouck, P., Noyelle, K. & Van Dael, H. (1998). Equilibrium and kinetic folding of pigeon lysozyme. Biochemistry 37, 6772-6780.
42. Itzhaki, L.S., Evans, P.A., Dobson, C.M. & Radford, S.E. (1994). Tertiary interactions in the folding pathway of hen lysozyme: kinetic studies using fluorescent probes. Biochemistry 33, 5212-5220.
43. Lu, H., Buck, M., Radford, S.E. & Dobson, C.M. (1997) Acceleration of the folding of hen lysozyme by trifluoroethanol. J. Mol. Biol. 265, 112-117.
44. Engelhard, M. & Evans, P.A. (1995) Kinetics of interaction of partially folded proteins with a hydrophobic dye: Evidence that molten globule character is maximal in early folding intermediates. Protein Sci. 4, 1553-1562.
45. Ptitsyn, O.B., Pain, R.H., Semisotnov, G.V., Žerovnik, E. & Razgulyaev, O.I. (1990) Evidence for a molten globule state as a general intermediate in protein folding. FEBS Lett. 262, 20-24.
46. Fink, A.L., Calciano, L.J., Goto, Y., Kurotsu, T. & Palleros, D.R. (1994) Classification of acid denaturation of proteins: intermediates and unfolded states. Biochemistry 33, 12504-12511.
47. Fink, A.L., Calciano, L.J., Goto, Y., Nishimura, M. & Swedberg, S.A. (1993) Characterization of the stable, acid induced molten globule-like state of staphylococcal nuclease. Protein Sci. 2, 1155-1160.
48. Ward, L., Matthews, J.M., Zhang, J.G. & Simpson, R.J. (1995) Equilibrium denaturation of recombinant murine interleukin-6: effect of pH, denaturants and salt on formation of folding intermediates. Biochemistry 34, 11652-11659.
49. Kuroda, Y., Kidokoro, S. & Wada, A. (1992) Thermodynamic characterization of cytochrome c at low pH. Observation of the molten globule state and of the cold denaturation process. J. Mol. Biol. 223, 1139-1153.
50. Narhi Owers, L., Rosenfield, R., Wen, J., Arakawa, T., Prestrelski, S.J. & Philo, J.S. (1993) Acid-induced unfolding of brain-derived neurotropic factor results in the formation of a monomeric "A state". Biochemistry 32, 10819-10825.
51. Dryden, D. & Weir, P.M. (1991) Evidence for an acid-induced molten globule state in interleukin-2; a fluorescence and circular dichroism study. Biochem. Biophys. Acta 1078, 94-100.
52. Christensen, H. & Pain, R.H. (1994) The contribution of the molten globule model. In Mechanisms of Protein Folding (Pain, R.H., ed.), pp. 55-79. Oxford University Press, Oxford, UK.
53. Ptitsyn, O.B. (1992) The molten globule state. In Protein Folding (Creighton, T., ed.). pp. 243-300. Freeman, New York, USA.
54. Kuwajima, K. (1989) The molten globule state as a clue for understanding the folding and cooperativity of globular-protein structure. Proteins 6, 87-103.
55. Eliezer, D., Yao, J., Dyson, H.J. & Wright, P.E. (1998) Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding. Nature Struct. Biol. 5, 148-155.
56. Jerala, R., Žerovnik, E., Kidriě, J. & Turk, V. (1998) pH induced conformational transitions of the propeptide of human cathepsin L: a role for a molten globule state in zymogen activation. J. Biol. Chem. 273, 11498-11504.
57. Neet, K.E. & Timm, D.E. (1994) Conformational stability of dimeric proteins: quantitative studies by equilibrium denaturation. Protein Sci. 3, 2167-2174.
58. Mok, J.K., Bycroft, M. & de Prat-Gay, G. (1996) The dimeric DNA binding domain of the human papilloma vires E2 protein folds through a monomeric intermediate which cannot be native-like. Nature Struc. Biol. 3, 711-717.
59. Blocki, F.A., Schlievert, P.M. & Wackett, L.P. (1992) Rat liver protein linking chemical and immunological detoxification systems. Nature 360, 269-270.
60. Nishihim, J., Kuriyama, T., Sakai, M., Nishi, S., Ohki, S. & Hikichi, K. (1995) The structure and physicochamical properties of rat liver macrophage migration inhibitory factor. Biochem. Biophys. Acta 1247, 159-162.
61. Ikeguchi, M., Kuwajima, K., Mitani, M. & Sugai, S. (1986) Evidence for identity between the equilibrium unfolding intermediate and a transient folding intermediate: a comparative study of the folding reactions of lactalbumin and lysozyme. Biochemistry 25, 6965-6972.
62. Xu, Y., Mayne, L. & Eglander, S.W. (1998) Evidence for an unfolding and refolding pathway in cytochrome C. Nature Struct. Biol. 5, 774-778.
63. Radford, S.E., Dobson, C.M. & Evans, P.A. (1992) The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature 358, 302-307.
64. Shasty, M.C.R. & Udgaonkar, J.B. (1995) The folding mechanism of barstar: Evidence for multiple pathways and multiple intermediates. J. Mol. Biol. 247, 1013-1027.
65. Schmid, F.X. (1992) Kinetics of unfolding and refolding of single domain proteins. In Protein Folding (Creighton, T., ed.). pp. 197-238. Freeman, New York, USA.
66. Nall, B.T. (1994) Proline isomerization as a rate-limiting step. In Mechanisms of Protein Folding (Pain, R.H., ed.). Oxford University Press, New York, USA